ArticleHaematologica2026
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.
Mengyao Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleHaematologica2026
Mengyao Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.